VSee Health, Inc. Net Income (Loss) Attributable to Noncontrolling Interest
VSee Health, Inc. (VSEE) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 3-month period ending 2025-06-30, per its 10-Q/A filed 2025-11-20.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2025-11-20
- VSee Health, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-06-30 was $0.00.
- VSee Health, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- VSee Health, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2024-06-30 was -$31.98K.
- VSee Health, Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2024-03-31 was $31.98K.
- VSee Health, Inc. net income (loss) attributable to noncontrolling interest for fiscal 2023 was $37.48K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 10-Q/A · filed 2025-11-20 | $0.00 10-Q/A · filed 2025-11-20 | ||
| 2025-03-31 | $0.00 10-Q · filed 2025-10-15 | |||
| 2024-06-30 | -$31.98K 10-Q/A · filed 2025-11-20 | $0.00 10-Q/A · filed 2025-11-20 | $33.75K derived: sum of 3 quarters · filed 2025-11-20 | $46.21K derived: sum of 4 quarters · filed 2025-11-20 |
| 2024-03-31 | $31.98K 10-Q · filed 2025-10-15 | $65.73K derived: sum of 2 quarters · filed 2025-10-15 | $78.19K derived: sum of 3 quarters · filed 2025-10-15 | $74.22K derived: sum of 4 quarters · filed 2025-10-15 |
| 2023-12-31 | $33.75K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-29 | $46.21K derived: sum of 2 quarters · filed 2025-08-29 | $42.24K derived: sum of 3 quarters · filed 2025-08-29 | $37.48K 10-K/A · filed 2025-08-29 |
| 2023-09-30 | $12.46K 10-Q · filed 2024-11-14 | $8.49K derived: sum of 2 quarters · filed 2024-11-14 | $3.73K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$3.97K 10-Q · filed 2024-11-14 | -$8.74K 10-Q · filed 2024-09-23 | ||
| 2023-03-31 | -$4.77K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |